No abstract available
Keywords:
Immune checkpoints; Immunothérapie; Nivolumab; Oncologie; Oncology; PD-1; Pharmacologie; Pharmacology.
MeSH terms
-
Antibodies, Monoclonal / pharmacokinetics
-
Antibodies, Monoclonal / therapeutic use*
-
Antineoplastic Agents / pharmacokinetics
-
Antineoplastic Agents / therapeutic use*
-
Biomarkers
-
Gastrointestinal Microbiome / immunology
-
Humans
-
Immune System
-
Immunotherapy*
-
Neoplasms / drug therapy*
-
Nivolumab
-
Pharmacology, Clinical*
-
Programmed Cell Death 1 Receptor / antagonists & inhibitors
-
T-Lymphocytes / immunology
Substances
-
Antibodies, Monoclonal
-
Antineoplastic Agents
-
Biomarkers
-
Programmed Cell Death 1 Receptor
-
Nivolumab